Dual-Drug Conjugated Glyco-Nanoassemblies for Tumor-Triggered Targeting and Synergistic Cancer Therapy

被引:8
作者
Katmerlikaya, Tugba Gencoglu [1 ]
Dag, Aydan [5 ]
Ozgen, Pinar Sinem Omurtag [2 ,3 ]
Ersen, Busra Cetin [4 ]
机构
[1] Bezmialem Vakif Univ, Inst Hlth Sci, Dept Biotechnol, TR-34093 Istanbul, Turkey
[2] Istanbul Medipol Univ, Sch Pharm, Dept Analyt Chem, TR-34810 Istanbul, Turkey
[3] Marmara Univ, Fac Pharm, Dept Basic Pharm Sci, TR-34854 Istanbul, Turkey
[4] Ankara Haci Bayram Veli Univ, Inst Grad Studies, Dept Chem, TR-06900 Ankara, Turkey
[5] Bezmialem Vakif Univ, Fac Pharm & Pharmaceut Applicat & Res Ctr, Dept Pharmaceut Chem, TR-34093 Istanbul, Turkey
关键词
glyco-nanoassemblies; gemcitabine; cisPt; cellular uptake; synergistic chemotherapy; GEMCITABINE; DELIVERY;
D O I
10.1021/acsabm.2c00749
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Drug-conjugated nanoassemblies potentiate the efficiency of anticancer drugs through the advantages of high drug-loading capacity and passive/active targeting ability in cancer therapy. This study describes the synthesis of gemcitabine (Gem) and cisplatin (cisPt) dual-drug-functionalized glyco-nanoassemblies (GNs) for anticancer drug delivery systems. It also investigates the pH-triggered drug delivery of the conventional anticancer drug cisPt. A Gem-functionalized well-defined glycoblock copolymer backbone (P(iprFruMA-b-MAc)-Gem), which consists of fructose and methacrylic acid segments, was synthesized via a reversible addition-fragmentation chain transfer (RAFT) polymerization method. Following the hydrolysis of the protecting groups on the backbone copolymer, cisPt functionalization of P(FruMA-b-MAc)-Gem in aqueous media was carried out during the transformation of glycoblock polymers into self-assembled spherical glyco-nanoassemblies (GN3). Monodrug-functionalized glyco-nanoassemblies were also prepared either with Gem (GN1) or cisPt (GN2) to compare the synergetic effect of dual-drug conjugated glyco-nanoassemblies (GN3). The sizes of glyco-nanoassemblies GN1, GN2, and GN3 were found as 5.76 +/- 0.64, 59.80 +/- 0.13, and 53.80 +/- 3.90 nm and dispersity (D) values as 0.476, 0.292, and 0.311 by dynamic light scattering (DLS) measurement, respectively. The in vitro studies revealed that the drug-free glyco-nanoassemblies are biocompatible at concentrations higher than 296 mu g/mL. The drug-conjugated glyco-nanoassemblies (GN1 and GN2) exhibited in vitro cytotoxicity against human breast cancer cell lines of MDA-MB-231 comparable to free Gem and cisPt, illustrating an efficient drug release into the tumor environment. Additionally, GNs exhibited higher selectivity and preferential cellular internalization in MDA-MB-231 when compared to healthy cell lines of CCD-1079Sk. These dual-drug conjugated GNs can effectively enhance the killing of cancer cells and increase synergistic chemotherapy.
引用
收藏
页码:5356 / 5364
页数:9
相关论文
共 50 条
  • [41] In vitro and in vivo Study of a Novel Liposome-Mediated Dual Drug Delivery for Synergistic Lung Cancer Therapy via Oral Administration
    Zhou, Qi
    Fu, Zhiqiang
    ONCOTARGETS AND THERAPY, 2020, 13 : 12695 - 12703
  • [42] Microwave Absorbing Fe3O4@mTiO2 Nanoparticles as an Intelligent Drug Carrier for Microwave-Triggered Synergistic Cancer Therapy
    Peng, Hongxia
    Hu, Jilin
    Hu, Chuanyue
    Wu, Tengyan
    Tian, Xiuying
    JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2017, 17 (08) : 5139 - 5146
  • [43] Drug-Loaded Star-Shaped pH-Responsive Monomolecular Copolymer Nanocarriers for Tumor Targeting and Cancer Therapy
    Li, Qiu
    Jin, Yiguang
    Li, Miao
    Dong, Jun-Xing
    ACS BIOMATERIALS SCIENCE & ENGINEERING, 2015, 1 (03): : 175 - 182
  • [44] In Vivo Multimodality Imaging and Cancer Therapy by Near-Infrared Light-Triggered trans-Platinum Pro-Drug-Conjugated Upconverison Nanoparticles
    Dai, Yunlu
    Xiao, Haihua
    Liu, Jianhua
    Yuan, Qinghai
    Ma, Ping'an
    Yang, Dongmei
    Li, Chunxia
    Cheng, Ziyong
    Hou, Zhiyao
    Yang, Piaoping
    Lin, Jun
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2013, 135 (50) : 18920 - 18929
  • [45] Theranostic nanoparticles with tumor-specific enzyme-triggered size reduction and drug release to perform photothermal therapy for breast cancer treatment
    Liu, Rui
    Hu, Chuan
    Yang, Yuanyuan
    Zhang, Jingqing
    Gao, Huile
    ACTA PHARMACEUTICA SINICA B, 2019, 9 (02) : 410 - 420
  • [46] Self-immolative polyprodrug-based tumor-specific cascade amplificated drug release nanosystem for orchestrated synergistic cancer therapy
    Wang, Kewei
    Xiao, Xuan
    Liu, Ye
    Zong, Qingyu
    Tu, Yalan
    Yuan, Youyong
    BIOMATERIALS, 2022, 289
  • [47] Tumor-targeting multi-shelled hollow nanospheres as drug loading platforms for imaging-guided combinational cancer therapy
    Wan, Wentao
    Zhen, Tao
    Zhan, Ming
    Zhan, Qicheng
    Wu, Fan
    Li, Yihan
    Zhan, Lin
    Zhan, Jun
    Wan, Mingqian
    Su, Yi
    BIOMATERIALS SCIENCE, 2020, 8 (06) : 1748 - 1758
  • [48] Tumor-Targeting Polycaprolactone Nanoparticles with Codelivery of Paclitaxel and IR780 for Combinational Therapy of Drug-Resistant Ovarian Cancer
    Pan, Qianqian
    Tian, Jingjun
    Zhu, Huihui
    Hong, Liangjie
    Mao, Zhengwei
    Oliveira, Joaquim Miguel
    Reis, Rui L.
    Li, Xiao
    ACS BIOMATERIALS SCIENCE & ENGINEERING, 2020, 6 (04) : 2175 - 2185
  • [49] Drug-loaded titanium dioxide nanoparticle coated with tumor targeting polymer as a sonodynamic chemotherapeutic agent for anti-cancer therapy
    Kim, Seonil
    Im, Sooseok
    Park, Eun-Yeong
    Lee, Junseok
    Kim, Chulhong
    Kim, Tae-il
    Kim, Won Jong
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2020, 24
  • [50] Targeting death receptors for drug-resistant cancer therapy: Codelivery of pTRAIL and monensin using dual-targeting and stimuli-responsive self-assembling nanocomposites
    Xu, Fan
    Zhong, Huihai
    Chang, Ya
    Li, Dongdong
    Jin, Hongyue
    Zhang, Meng
    Wang, Huiyuan
    Jiang, Chen
    Shen, Youqing
    Huang, Yongzhuo
    BIOMATERIALS, 2018, 158 : 56 - 73